Empagliflozin alleviates type 2 diabetic renal fibrosis by inhibiting SLC7A7-mediated ferroptosis.

Empagliflozin 透過抑制 SLC7A7 介導的 ferroptosis，減輕第二型糖尿病腎臟纖維化。